Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE(–/–) Mice

AIM: Glucagon-like peptide-1 (GLP1) is known to decrease glucagon release and may be beneficial for the reduction of elevated blood glucose. However, its role and mechanism of action in diabetes remain elusive. This study aimed to examine the function of GLP1 and analyze the mechanism of effect that...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fuqiang, Gong, Lei, Qin, Weidong, Cui, Chen, Chen, Li, Zhang, Mingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395686/
https://www.ncbi.nlm.nih.gov/pubmed/32801816
http://dx.doi.org/10.2147/DMSO.S262479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395686/
https://www.ncbi.nlm.nih.gov/pubmed/32801816
http://dx.doi.org/10.2147/DMSO.S262479

Ejemplares similares